DK2379580T3 - Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner - Google Patents

Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner

Info

Publication number
DK2379580T3
DK2379580T3 DK09795876.3T DK09795876T DK2379580T3 DK 2379580 T3 DK2379580 T3 DK 2379580T3 DK 09795876 T DK09795876 T DK 09795876T DK 2379580 T3 DK2379580 T3 DK 2379580T3
Authority
DK
Denmark
Prior art keywords
antibacterial agents
treating gram
positive infections
unknown
unknown antibacterial
Prior art date
Application number
DK09795876.3T
Other languages
Danish (da)
English (en)
Inventor
Andre Lee Pearson
Chester A Metcalf Iii
Jing Li
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Application granted granted Critical
Publication of DK2379580T3 publication Critical patent/DK2379580T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09795876.3T 2008-12-22 2009-12-18 Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner DK2379580T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13987508P 2008-12-22 2008-12-22
PCT/US2009/068747 WO2010075215A1 (en) 2008-12-22 2009-12-18 Novel antibacterial agents for the treatment of gram positive infections

Publications (1)

Publication Number Publication Date
DK2379580T3 true DK2379580T3 (da) 2014-01-20

Family

ID=41718893

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09795876.3T DK2379580T3 (da) 2008-12-22 2009-12-18 Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner

Country Status (26)

Country Link
US (3) US8507647B2 (https=)
EP (2) EP2379580B1 (https=)
JP (1) JP5670914B2 (https=)
KR (1) KR101717795B1 (https=)
CN (1) CN102325787B (https=)
AR (1) AR074833A1 (https=)
AU (1) AU2009330245C1 (https=)
BR (1) BRPI0923567A2 (https=)
CA (1) CA2747965C (https=)
CY (1) CY1114883T1 (https=)
DK (1) DK2379580T3 (https=)
ES (1) ES2442167T3 (https=)
HR (1) HRP20131170T1 (https=)
IL (1) IL213638A0 (https=)
MX (1) MX2011006803A (https=)
NZ (1) NZ594019A (https=)
PL (1) PL2379580T3 (https=)
PT (1) PT2379580E (https=)
RS (1) RS53152B (https=)
RU (1) RU2512396C2 (https=)
SG (1) SG172299A1 (https=)
SI (1) SI2379580T1 (https=)
SM (1) SMT201400037B (https=)
TW (1) TWI444198B (https=)
WO (1) WO2010075215A1 (https=)
ZA (1) ZA201104693B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013157188A (ru) * 2011-05-26 2015-07-10 Кьюбист Фармасьютикалз, Инк. Композиции св-183,315 и относящиеся к ним способы
US10377699B2 (en) * 2013-11-06 2019-08-13 The University Of Hong Kong Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
ES2791319T3 (es) * 2016-04-22 2020-11-03 Astrazeneca Ab Inhibidores de MCL1 macrocíclicos para tratar el cáncer
US10098890B2 (en) 2016-10-29 2018-10-16 Cipla Limited Stable carfilzomib formulations
IT201600127655A1 (it) * 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
EP0087953B1 (en) 1982-02-27 1988-04-27 Beecham Group Plc Antibacterial 1-normon-2-yl-heterocyclic compounds
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) * 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
SU1452484A3 (ru) 1984-10-09 1989-01-15 Эли Лилли Энд Компани (Фирма) Способ получени производных антибиотиков А-21978С, штамм стрептомицета SтRертомYсеS RoSeoSpoRUS, используемый дл получени антибиотических веществ А-21978С
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
ES2089133T3 (es) * 1990-06-07 1996-10-01 Lilly Co Eli Desacilasa de lipopeptidos.
AU7497594A (en) 1993-08-13 1995-03-14 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69739532D1 (de) 1996-03-08 2009-09-24 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
PL203689B1 (pl) 1998-09-25 2009-11-30 Cubist Pharmaceuticals Zastosowanie daptomycyny
EP1279057B1 (en) 1999-11-03 2013-03-20 The Whitaker LLC Optoelectric module for multi-fiber arrays
MXPA02006028A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
WO2001044274A1 (en) 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
CN1425025A (zh) 1999-12-15 2003-06-18 卡比斯特制药公司 作为抗菌剂的新颖的脂肽
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
RU2348647C2 (ru) 2001-08-06 2009-03-10 Кьюбист Фармасьютикалз, Инк Новые депсипептиды и способы их получения
WO2006110185A2 (en) 2004-11-12 2006-10-19 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides

Also Published As

Publication number Publication date
US8507647B2 (en) 2013-08-13
CA2747965A1 (en) 2010-07-01
RU2011130278A (ru) 2013-01-27
AR074833A1 (es) 2011-02-16
RU2512396C2 (ru) 2014-04-10
EP2674437A1 (en) 2013-12-18
SG172299A1 (en) 2011-07-28
EP2379580B1 (en) 2013-10-23
RS53152B (sr) 2014-06-30
AU2009330245A1 (en) 2011-08-04
KR101717795B1 (ko) 2017-03-17
JP2012513467A (ja) 2012-06-14
WO2010075215A1 (en) 2010-07-01
TWI444198B (zh) 2014-07-11
NZ594019A (en) 2013-08-30
HK1161886A1 (en) 2012-08-10
KR20110114592A (ko) 2011-10-19
HRP20131170T1 (hr) 2014-01-03
BRPI0923567A2 (pt) 2016-09-27
SMT201400037B (it) 2014-05-07
US20140073558A1 (en) 2014-03-13
US20150337013A1 (en) 2015-11-26
JP5670914B2 (ja) 2015-02-18
CY1114883T1 (el) 2016-12-14
EP2379580A1 (en) 2011-10-26
ZA201104693B (en) 2013-01-30
CN102325787B (zh) 2014-05-28
CN102325787A (zh) 2012-01-18
PL2379580T3 (pl) 2014-05-30
MX2011006803A (es) 2011-09-06
US20100184649A1 (en) 2010-07-22
SI2379580T1 (sl) 2014-02-28
PT2379580E (pt) 2014-01-20
IL213638A0 (en) 2011-07-31
ES2442167T3 (es) 2014-02-10
TW201028161A (en) 2010-08-01
AU2009330245B2 (en) 2013-05-02
CA2747965C (en) 2017-06-27
AU2009330245C1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
DK2379580T3 (da) Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner
SMT201500117B (it) Composti antibatterici
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
BRPI0820656A2 (pt) Tiazóis condensados antibacterianos
EP2223788A4 (en) CUT PROCESSING MECHANISM
ATE507225T1 (de) Antibakterielle polycyclische harnstoffverbindungen
DE602008003471D1 (de) Schlüsselloses Zugangssystem
DK2331687T3 (da) Antimikrobielle midler
BRPI0915059A2 (pt) conjunto de cateter de lavagem broncoalveolar
PL2464645T3 (pl) Skondensowane heterocykliczne związki jako modulatory kanałów jonowych
BRPI0919695A2 (pt) proporcionando resultados de pesquisa
BRPI0917289A2 (pt) revestimento polimérico de halo-hidrocarboneto
DK2350116T3 (da) Behandling af biofilm
EP2173170A4 (en) ANNEXED HETEROCYCLES
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
BR112012008061A2 (pt) compostos de oxima heterocíclica
DK2353259T3 (da) Meddelelsesforarbejdning
DK2330887T3 (da) Behandlingsindretning
GB0816679D0 (en) Compounds for treating viral infections
BRPI0920895A2 (pt) compostos antibióticos de oxazolidinona tricíclica
EP2460405A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCE
DK2235041T3 (da) Antimikrobielle forbindelser
EP2358768A4 (en) Crosslinked polyvinylpyrrolidone compositions
HRP20150195T1 (xx) Antibakterijski peptidi
DK2164572T3 (da) Carbamoyl-cyclohexaner til behandling af akut mani